IRCT2014062318202N1已完成未知
The impact of next generation sequencing (NGS) preimplantation genetic diagnostics (PGD) on pregnancy rate of frozen blastocyst embryo transfer.
Invicta s.z o.o.0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 33 years 至 42 years（—）
- 性别
- All
入选标准
- •Incusion: 1. Patients undergoing assisted reproductive treatment with intracytoplasmic sperm injection and frozen blastocyst embryotransfer in Invicta Fertility and Reproductive Centre s. z o.o. in time frame from 08.2014 to 09.2014
- •Exclusion: 1. Blastocysts in stages 2CC, 3CC, 4CC, and 5CC did not qualify for biopsy.
- •2.Patients in whom no normal embryo was available
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
Validity of next-generation sequencing (NGS)-based gene panel testing in endoscopic ultrasound with bronchoscope-guided fine needle aspiration (EUS-B-FNA) specimens in patients with lung cancer: a prospective studyPrimary lung cacnerJPRN-UMIN000050354niversity of Fukui50
招募中
Unknown
Validity of next-generation sequencing (NGS)-based gene panel testing in endoscopic ultrasound with endobronchial ultrasound-guided transbronchial needle aspiration or endobronchial ultrasound-guided transbronchial needle aspiration specimens in patients with lung cancer: a prospective studyPrimary lung cacnerJPRN-UMIN000052391niversity of Fukui50
已完成
不适用
Routine use of next generation sequencing (NGS) for preimplantation genetic diagnostics (PGD) of blastomeres obtained from embryos on day 3 in fresh IVF cycles.infertility.Female infertility, unspecifiedIRCT2014070118202N2Invicta s.z o.o.28
已完成
不适用
A prospective study of the usefulness of next-generation sequencing, circulating tumor DNA (ctDNA), and exosome DNA as biomarkers in esophageal squamous cell carcinomaesophageal squamous cell cancerJPRN-UMIN000045311Wakayama medical university50
尚未招募
不适用
ongitudinal Next Generation Sequencing (NGS) in Patients with Relapsing-Remitting Multiple Sclerosis (Systematic investigation of genomic activity in patients with RR-MS)G35.1DRKS00006351ovartis GmbH10